Search filters

List of works by Elizabeth I Buchbinder

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

article

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

scientific article published on 22 July 2019

A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade

scientific article published on 14 September 2020

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma.

scientific article

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma

scientific article published on 20 September 2016

An immunogenic personal neoantigen vaccine for patients with melanoma

scientific article

Biomarkers in Melanoma: Lessons from Translational Medicine

scientific article

CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition

scientific article

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

scientific article published on 27 October 2017

Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2

Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma

scientific article published on 10 April 2017

Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma

scientific article

Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients

scientific article published on 01 February 2019

Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

scholarly article by Girish S Naik et al published 29 March 2019 in Journal for Immunotherapy of Cancer

Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma

scientific article published in Nature

Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade

scientific article published on September 2015

Cytotoxic T-lymphocyte antigen-4 blockade in melanoma

scientific article

Erratum to: Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

scientific article

Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

scientific article

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study

scientific article published on 15 December 2017

Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions

scientific article

Immunotherapy Toxicity

scientific article published on 28 January 2019

Inactivation of Fbxw7 impairs dsRNA sensing and confers resistance to PD-1 blockade

scientific article published on 05 May 2020

Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer

scientific article published on 12 June 2011

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data

scientific article

Interferon, interleukin-2, and other cytokines

scientific article published on 03 April 2014

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

scientific article

Melanoma arising in a nevus of Ito: novel genetic mutations and a review of the literature on cutaneous malignant transformation of dermal melanocytosis

scientific article published on 11 August 2015

Melanoma in 2015: Immune-checkpoint blockade - durable cancer control.

scientific article published on 20 January 2016

Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)

scientific article published on 15 June 2020

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

scientific article published on 21 January 2021

Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma

scientific article published on 11 August 2015

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)

scientific article published on 13 December 2012

Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit

scientific article published on 29 July 2020

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation

scientific article

Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge

scientific article

Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis

scientific article published on 13 May 2020

Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF Inhibition

scientific article published on 14 November 2016

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial

scientific article

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

scientific article published on 16 October 2020

Severe radiation necrosis refractory to surgical resection in patients with melanoma and brain metastases managed with ipilimumab/nivolumab and brain-directed stereotactic radiation therapy

scientific article published on 21 April 2020

The Evolution of Adjuvant Therapy for Melanoma

scientific article published on 25 November 2019

The Phoenix Rises: The Rebirth of Cancer Immunotherapy

scientific article published on 17 May 2017

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

scientific article published on 18 February 2019

Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis

scientific article published on 22 June 2020

Paulina is supported by:

About Paulina

Help